These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11420)
1. Dexclamol: effects on catecholamine metabolism and demonstration of stereochemical specificity of antagonism of central adrenergic receptors. Pugsley TA; Lippmann W Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):117-22. PubMed ID: 11420 [TBL] [Abstract][Full Text] [Related]
2. Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. Pugsley TA; Merker J; Lippman W Can J Physiol Pharmacol; 1976 Aug; 54(4):510-5. PubMed ID: 10057 [TBL] [Abstract][Full Text] [Related]
3. A study of the effects of dexclamol as the neuroleptic component in neuroleptanaesthesia. Jaramilio J Br J Anaesth; 1976 Dec; 48(12):1149-55. PubMed ID: 1023951 [TBL] [Abstract][Full Text] [Related]
4. Dexclamol, a candidate for neuroleptanalgesia. Jaramillo J Can J Physiol Pharmacol; 1976 Apr; 54(2):140-5. PubMed ID: 1276987 [TBL] [Abstract][Full Text] [Related]
5. Effects of CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl] butyl]-2,-4-imidazolidinedione), an antihypertensive agent, on rat brain catecholamine and serotonin turnover. Pugsley TA; Myers SM; Shih YH J Cardiovasc Pharmacol; 1989 Mar; 13(3):455-64. PubMed ID: 2471893 [TBL] [Abstract][Full Text] [Related]
6. Conformational analysis and structural comparisons of (1R,3S)-(+)- and (1S,3R)-(-)-tefludazine, (S)-(+)- and (R)-(-)-octoclothepin, and (+)-dexclamol in relation to dopamine receptor antagonism and amine-uptake inhibition. Liljefors T; Bøgesø KP J Med Chem; 1988 Feb; 31(2):306-12. PubMed ID: 2892932 [TBL] [Abstract][Full Text] [Related]
7. Age-dependent changes in 24-hour rhythms of catecholamine content and turnover in hypothalamus, corpus striatum and pituitary gland of rats injected with Freund's adjuvant. Cano P; Cardinali DP; Chacon F; Castrillón PO; Reyes Toso CA; Esquifino AI BMC Physiol; 2001; 1():14. PubMed ID: 11741510 [TBL] [Abstract][Full Text] [Related]
8. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments. Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178 [TBL] [Abstract][Full Text] [Related]
9. Carbamazepine decreases catecholamine turnover in the rat brain. Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972 [TBL] [Abstract][Full Text] [Related]
10. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice. Lin Z; Dodd CA; Filipov NM Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127 [TBL] [Abstract][Full Text] [Related]
11. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects. Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753 [TBL] [Abstract][Full Text] [Related]
12. Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices. Reserpine-like effects of haloperidol. Delanoy RL; Dunn AJ Biochem Pharmacol; 1982 Oct; 31(20):3297-305. PubMed ID: 7150356 [TBL] [Abstract][Full Text] [Related]
13. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart. Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909 [TBL] [Abstract][Full Text] [Related]
14. Effects of fentanyl and droperidol on the dopamine metabolism of the rat striatum. Freye E; Kuschinsky K Pharmacology; 1976; 14(1):1-7. PubMed ID: 986654 [TBL] [Abstract][Full Text] [Related]
15. Lability in storage of 3H-dopamine and 3H-norepinephrine in crude synaptosome (P2) and vesicle-associated fractions of rat brain. Bianchi BR; Takimoto GS Life Sci; 1984 Feb; 34(7):607-15. PubMed ID: 6700371 [TBL] [Abstract][Full Text] [Related]
16. The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Westfall TC; Besson MJ; Giorguieff MF; Glowinski J Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(3):279-87. PubMed ID: 181686 [TBL] [Abstract][Full Text] [Related]
17. The effect of various stimulated altitudes on the turnover of norepinephrine and dopamine in the central nervous system of rats. Prioux-Guyonneau M; Cretet E; Jacquot C; Rapin JR; Cohen Y Pflugers Arch; 1979 Jun; 380(2):127-32. PubMed ID: 573440 [TBL] [Abstract][Full Text] [Related]
18. Noradrenergic terminals are the primary source of α Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. Sacaan AI; Dunlop JL; Lloyd GK J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine. Uretsky NJ; Snodgrass SR; Lorenzo AV J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]